Worth reading
93Important
Scored from 1 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
264
¥ millionWording
Definitive
How definitive the wording is.Details of issuance or disposal
Issuance through a third-party allotment of Series 2 Unsecured Convertible Bond-Type Bonds with Stock Acquisition Rights and Series 10 Stock Acquisition Rights (this disclosure concerns a change in the use of funds)
Total issue value
¥1,294 million raised through the issuance of the Series 2 Bonds with Stock Acquisition Rights and ¥6 million raised through the issuance of the Series 10 Stock Acquisition Rights
Amount of funds to be raised
¥1,300 million raised to date (¥1,294 million from the Series 2 Bonds with Stock Acquisition Rights and ¥6 million from the issuance of the Series 10 Stock Acquisition Rights), ¥1,521 million yet to be raised (the expected amount to be raised through the exercise of the Series 10 Stock Acquisition Rights), for a total of ¥2,805 million
Estimated issuance expenses
¥19 million
Specific use of funds
Working capital (funds to maintain liquidity on hand)Amount ¥194 million from the Series 2 Bonds with Stock Acquisition Rights and ¥411 million from the Series 10 Stock Acquisition Rights / Scheduled timing of expenditures Series 2 Bonds with Stock Acquisition Rights: February 2026 to February 2028; Series 10 Stock Acquisition Rights: June 2026 to February 2028
Business investment (real estate acquisitions, security deposits and opening costs for operating hotels)Amount ¥400 million from the Series 2 Bonds with Stock Acquisition Rights and ¥400 million from the Series 10 Stock Acquisition Rights / Scheduled timing of expenditures Series 2 Bonds with Stock Acquisition Rights: February 2026 to February 2028; Series 10 Stock Acquisition Rights: June 2026 to February 2028
New business funding (corporate M&A and new businesses [including AI and Web3])Amount ¥700 million from the Series 2 Bonds with Stock Acquisition Rights and ¥700 million from the Series 10 Stock Acquisition Rights / Scheduled timing of expenditures Series 2 Bonds with Stock Acquisition Rights: June 2026 to February 2028; Series 10 Stock Acquisition Rights: June 2026 to February 2028
Bond repayment (principal and interest)Amount — (¥264 million before the change) / Scheduled timing of expenditures — (May 2026 before the change)
Most recent equity financing
Timing Disclosure dated 22 January 2026 / Type Issuance through a third-party allotment of Series 2 Unsecured Convertible Bond-Type Bonds with Stock Acquisition Rights and Series 10 Stock Acquisition Rights / Amount ¥2,805 million
Impact on Business Performance
The impact of the change in the use of funds on consolidated results for the current fiscal year is expected to be immaterial.
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance through a third-party allotment of Series 2 Unsecured Convertible Bond-Type Bonds with Stock Acquisition Rights and Series 10 Stock Acquisition Rights (this disclosure concerns a change in the use of funds) |
| Total issue value | ¥1,294 million raised through the issuance of the Series 2 Bonds with Stock Acquisition Rights and ¥6 million raised through the issuance of the Series 10 Stock Acquisition Rights |
| Amount of funds to be raised | ¥1,300 million raised to date (¥1,294 million from the Series 2 Bonds with Stock Acquisition Rights and ¥6 million from the issuance of the Series 10 Stock Acquisition Rights), ¥1,521 million yet to be raised (the expected amount to be raised through the exercise of the Series 10 Stock Acquisition Rights), for a total of ¥2,805 million |
| Estimated issuance expenses | ¥19 million |
| Specific use of funds | Details Working capital (funds to maintain liquidity on hand) / Amount ¥194 million from the Series 2 Bonds with Stock Acquisition Rights and ¥411 million from the Series 10 Stock Acquisition Rights / Scheduled timing of expenditures Series 2 Bonds with Stock Acquisition Rights: February 2026 to February 2028; Series 10 Stock Acquisition Rights: June 2026 to February 2028, Details Business investment (real estate acquisitions, security deposits and opening costs for operating hotels) / Amount ¥400 million from the Series 2 Bonds with Stock Acquisition Rights and ¥400 million from the Series 10 Stock Acquisition Rights / Scheduled timing of expenditures Series 2 Bonds with Stock Acquisition Rights: February 2026 to February 2028; Series 10 Stock Acquisition Rights: June 2026 to February 2028, Details New business funding (corporate M&A and new businesses [including AI and Web3]) / Amount ¥700 million from the Series 2 Bonds with Stock Acquisition Rights and ¥700 million from the Series 10 Stock Acquisition Rights / Scheduled timing of expenditures Series 2 Bonds with Stock Acquisition Rights: June 2026 to February 2028; Series 10 Stock Acquisition Rights: June 2026 to February 2028, Details Bond repayment (principal and interest) / Amount — (¥264 million before the change) / Scheduled timing of expenditures — (May 2026 before the change) |
| Most recent equity financing | Timing Disclosure dated 22 January 2026 / Type Issuance through a third-party allotment of Series 2 Unsecured Convertible Bond-Type Bonds with Stock Acquisition Rights and Series 10 Stock Acquisition Rights / Amount ¥2,805 million |
| Impact on Business Performance | The impact of the change in the use of funds on consolidated results for the current fiscal year is expected to be immaterial. |
Items this document does not state (21)
Number of shares to be issued or disposed ofIssue price and disposal pricePayment dateIntended allotteeIntended allottee's holding policyDilution RateTotal number of issued sharesBasis for determining the amount to be paidExercise priceExercise periodNumber of Stock Acquisition RightsTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offering
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The Series 10 Stock Acquisition Rights have not been exercised as of the present date, and the bonds were redeemed using working capital from sources other than this financing, including repayment of principal and interest.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.